| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||||
|---|---|---|---|---|---|---|---|---|
| 2025-11-13 |
Mersana Therapeutics
Life Science Cambridge, Massachusetts www.mersana.com Mersana Therapeutics is a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. Mersana Therapeutics was founded in 2001 and is based in Cambridge, Massachusetts.
|
Merger
|
Day One
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2025-08-25 |
scPharmaceuticals
Life Science Burlington, Massachusetts www.scpharmaceuticals.com scPharmaceuticals is a commercial-stage pharmaceutical company focused on redefining cardiorenal care with integrated treatments designed to address the unmet needs of patients. scPharmaceuticals was founded in 2013 and is headquartered in Burlington, Massachusetts.
|
Merger
|
MannKind
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2025-06-05 |
BankProv
Financial Services Amesbury, Massachusetts www.bankprov.com BankProv is a full-service commercial bank headquartered in Massachusetts. With retail branches in the North Shore of Massachusetts and in southern New Hampshire, commercial banking offices in the Manchester/Concord market in Central New Hampshire and a loan office located in Ponte Vedra Beach, Florida, it delivers a unique combination of traditional banking services and innovative financial solutions to its markets. BankProv is based in Amesbury, Massachusetts.
|
Merger
|
Needham Bank
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2025-05-20 |
Colonial Federal Savings Bank
Financial Services Quincy, Massachusetts www.colonialfed.com Colonial Federal Savings Bank offers personal banking, mortgage lending, and savings products. Colonial Federal Savings Bank was founded in 1889 and is based in Quincy, Massachusetts.
|
Merger
|
bankHometown
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2025-04-24 |
HarborOne Bank
Financial Services Brockton, Massachusetts www.harborone.com HarborOne Bank provides consumer, small business, and commercial banking services, including checking and savings accounts, loans, mortgages, and online banking tools. The Bank also offers financial education programs and operates a mortgage division serving customers throughout New England. HarborOne Bank was founded in 1917 and is headquartered in Brockton, Massachusetts.
|
Merger |
Eastern Bank
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2025-03-19 |
Nova Biomedical
Healthcare Services Waltham, Massachusetts www.novabiomedical.com Nova Biomedical provides analytical instruments and consumables for the biopharmaceutical and clinical markets. The company’s clinical products provide point-of-care analysis and monitoring of critical analytes including blood gases and glucose used to diagnose and monitor patients in hospital settings. Its biopharmaceutical products provide mission-critical analytics for research laboratories and drug manufacturing facilities, accelerating and improving the drug development process and product quality. Nova is headquartered in Waltham, Massachusetts. Advisors: Davis Polk & Wardwell , Jefferies |
Merger |
Advanced Instruments
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2024-10-28 |
BetterVet
Consumer Services Boston, Massachusetts www.bettervet.com BetterVet is delivering veterinary services directly to pets' homes. With a strong focus on at-home visits & telehealth, BetterVet was founded in 2020 and is based in Boston, Massachusetts. |
Merger |
Vets
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2024-04-30 |
Deciphera
Life Science Waltham, Massachusetts www.deciphera.com Deciphera focuses on the discovery, development, and commercialization of innovative medicines for cancer and has deep expertise in kinase biology (see Table 1 below). QINLOCK (ripretinib), a KIT inhibitor, is approved in over 40 countries and marketed globally, including in the US, Europe, and China, for treatment of fourth-line gastrointestinal stromal tumor (GIST). Vimseltinib, a CSF-1R inhibitor, demonstrated statistically significant and clinically meaningful efficacy across all primary and secondary endpoints in the Phase III MOTION trial in patients with tenosynovial giant cell tumor (TGCT). Deciphera is based in Waltham, Massachusetts.
|
Merger
|
Ono Pharmaceutical
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2024-01-23 |
KCP
Business Services Billerica, Massachusetts www.kcpadvisory.com KCP renders services spanning a range of advisory roles from consulting to interim leadership. The company ensures the needs of the situation are met and minimizes the cost of valuable solutions by working in small, specialized expert teams. It provides the experience of a wide range of businesses and industries to assist a client whether they are healthy, challenged, or distressed and whether the challenges include performance improvement financial advisory services, or turnaround and restructuring. KCP is based in Billerica, Massachusetts. |
Merger |
Altman & Co.
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2024-01-19 |
Cynosure
Medical Products Westford, Massachusetts www.cynosure.com Cynosure is a developer and marketer of aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure was founded in 1991 and is based in Westford, Massachusetts. Advisors: Debevoise & Plimpton , Weil Gotshal & Manges , Jefferies |
Merger |
Lutronic
|
CD&R
|
||||
| Deal Article Deal Link | ||||||||
| 2023-12-04 |
Exclusive Concepts
Marketing Burlington, Massachusetts www.exclusiveconcepts.com Exclusive Concepts is a provider of digital marketing and advertising services for eCommerce-focused clients. Exclusive Concepts was founded in 1997 and is based in Burlington, Massachusetts. |
Merger |
Agital
|
Trinity Hunt Partners
|
||||
| Deal Article Deal Link | ||||||||
| 2023-09-22 |
Cambridge Trust
Financial Services Cambridge, Massachusetts www.cambridgetrust.com Cambridge Trust is a private bank that creates custom financial solutions to build, grow, and protect wealth for the needs of today’s individuals, families, businesses, private partnerships and nonprofit organizations. Cambridge Trust was founded in 1890 and is based in Cambridge, Massachusetts. Advisors: Hogan Lovells , BofA Securities |
Merger
|
Eastern Bank
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2023-09-11 |
Shift Media
Internet Software and Services Boston, Massachusetts www.shiftmedia.io Shift Media is a provider of cloud-based media collaboration and digital asset management solutions. SHIFT’s multi-tenant SaaS platform helps media and entertainment companies, advertising agencies and production houses securely create, share and collaborate on creative work at all stages of the content production lifecycle, embed visible and forensic watermarking into video and safely screen sensitive pre-release content. Shift Media is based in Boston, Massachusetts. |
Merger |
EditShare
|
Marlin Equity Partners
|
||||
| Deal Article Deal Link | ||||||||
| 2023-08-31 |
Acer
Life Science Newton, Massachusetts www.acertx.com Acer is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. In the U.S., OLPRUVA (sodium phenylbutyrate) is approved for the treatment of urea cycle disorders (UCDs) involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS). The company is advancing a pipeline of investigational product candidates for rare and life-threatening diseases, including: OLPRUVA (sodium phenylbutyrate) for treatment of various disorders, including Maple Syrup Urine Disease (MSUD); and EDSIVO (celiprolol) for treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation. Aceris based in Newton, Massachusetts. Advisors: Pillsbury Winthrop Shaw Pittman , William Blair |
Merger
|
Zevra Therapeutics
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2023-08-09 |
Decibel
Life Science Boston, Massachusetts www.decibeltx.com Decibel is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance. It has built a proprietary platform that integrates single-cell genomics and bioinformatic analyses, precision gene therapy technologies, and expertise in inner ear biology. The company is leveraging its platform to advance gene therapies designed to selectively replace genes for the treatment of congenital, monogenic hearing loss and to regenerate inner ear hair cells for the treatment of acquired hearing and balance disorders. Its pipeline, including its lead gene therapy program, DB-OTO, to treat congenital, monogenic hearing loss, is designed to deliver on our vision of a world in which the privileges of hearing and balance are available to all. Decibel was founded in 2013 and is based in Boston, Massachusetts. Advisors: Wilmer Cutler Pickering Hale and Dorr , Leerink Partners , Centerview Partners |
Merger
|
Regeneron Pharmaceuticals
|
- | ||||
| Deal Article Deal Link | ||||||||
| 2023-07-14 |
Korro Bio
Life Science Cambridge, Massachusetts www.korrobio.com Korro Bio RNA editing company focused on the discovery and development of novel genetic medicines. Korro Bio is based in Cambridge, Massachusetts. Advisors: Latham & Watkins , TD Securities |
Merger |
Korro Bio
|
- | ||||
| Deal Article Deal Link | ||||||||
| Avg |
$3,493
0.0x EBITDA 6.6x REVENUE |
|||||||
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.